Bioxis Pharmaceuticals is a France-based pharmaceutical company founded in 2010 that specializes in the discovery, clinical development, production, and commercialization of innovative products in the field of regenerative medicine. The company's focus lies in dermatology and aesthetic medicine. Their commitment to transforming science into groundbreaking medical devices is demonstrated through their slogan #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine. Their last €2.50M Venture Round investment on 23 September 2016 is proof of their appeal to investors, with Juvamed being the last investor. Bioxis Pharmaceuticals stands out in the biotechnology, medical devices, and pharmaceutical industries, reflecting their dedication to innovation and advancement in the medical field. The company's fresh ideas and innovative approach make it a promising venture for potential investors.
No recent news or press coverage available for Bioxis Pharmaceuticals.